Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

133%

4 of 3 completed trials have results

Key Signals

2 recruiting4 with results

Enrollment Performance

Analytics

N/A
6(75.0%)
Phase 2
2(25.0%)
8Total
N/A(6)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials
NCT05240352Not ApplicableRecruiting

Developing Brain Imaging Analysis Expertise for Personalizing Transcranial Electric Stimulation in Anhedonia Treatment of Patients With Bipolar Depression

Role: collaborator

NCT05427123Recruiting

Children's Bipolar Network Treatment Trial I

Role: collaborator

NCT05480124Not ApplicableCompleted

Bipolar Transcranial Alternating Current Stimulation (tACS)

Role: collaborator

NCT05179785Not ApplicableCompleted

Examining the Effect of EEG-guided Theta Burst Stimulation in Bipolar Disorder

Role: collaborator

NCT05340504Phase 2Completed

Evaluating the Hypothesized Mechanism of Action of N-acetylcysteine for Bipolar Disorder

Role: collaborator

NCT05393648Not ApplicableActive Not Recruiting

Bipolar Efficacy Biomarkers for rTMS

Role: collaborator

NCT05762887Not ApplicableUnknown

Clinical Evaluation of the Antidepressant Effect of the Use of Probiotics in Bipolar Disorder

Role: collaborator

NCT05354895Not ApplicableUnknown

Oxygenating the Brain With Laser Therapy

Role: collaborator

NCT00524134Phase 2Terminated

P-glycoprotein Inhibition as Adjunct Treatment for Medically Refractory Epilepsy.

Role: collaborator

All 9 trials loaded